Results 201 to 210 of about 119,640 (264)

Integrative Approaches to Treating Cellular Senescence in Kidney Disease

Advanced Science, EarlyView.
ABSTRACT Cellular senescence in the kidney plays a crucial role in the progression of acute kidney injury and chronic kidney disease. Therapeutic approaches targeting senescent cells, such as small molecule senolytic and senomorphic drugs, display efficacy in preclinical models.
Tomoka Misawa, Amruta A, LaTonya J. Hickson, Joy Wolfram   +3 more
wiley   +1 more source

Material strengths of shear-induced platelet aggregation clots and coagulation clots. [PDF]

Sci Rep
Kim DA, Ku DN.
europepmc   +1 more source

Bioanalytical method development, in-vivo pharmacokinetic evaluation, ex-vivo platelet aggregation inhibition activity of a novel solid dispersion formulation of ticagrelor. [PDF]

Front Med Technol
Srivastava A, Bedi S, Mehata AK, Pawde DM, Hatware KV, Khan MA, Muthu MS, Bhandari U.   +7 more
europepmc   +1 more source

Evaluation of an automated platelet aggregation method for detection of congenital or acquired platelet function defects. [PDF]

Blood Transfus
Lecchi A, Capecchi M, Padovan L, Artoni A, Arai N, Shinohara S, La Marca S, Peyvandi F.   +7 more
europepmc   +1 more source

Optimized Methodology to Produce Platelet-Rich Plasma and Perform Platelet Aggregation in Patients With Coronary Artery Disease. [PDF]

Cureus
Kashyap AK, Saikrishna B, Duggal B.
europepmc   +1 more source

[Platelet aggregation and platelet antiaggregants].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1988
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Platelet aggregation by platelet-clumping substance

Thrombosis Research, 1974
Abstract The platelet-clumping substance isolated from rabbit plasma by the authors aggregated washed rabbit platelets, while ADP did not. The presence of AMP or adenosine did not inhibit the appearance of platelet aggregation induced by the clumping substance.
H, Yamazaki, T, Sano, T, Shimamoto, T, Shimamoto   +3 more
openaire   +2 more sources

Platelet aggregation and platelet-inhibiting drugs

Neurochemical Pathology, 1987
Platelet function may cause a progression of central gray matter damage after cerebrospinal hemorrhage or trauma because of the thrombotic occlusion of injured vessels or a vasospasm induced by extravasated blood. It has therefore been suggested that antiplatelet drugs could limit the extent of the neurological lesions produced by a spinal trauma.
openaire   +2 more sources